BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22911670)

  • 1. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.
    Marshall JC; Collins JW; Nakayama J; Horak CE; Liewehr DJ; Steinberg SM; Albaugh M; Vidal-Vanaclocha F; Palmieri D; Barbier M; Murone M; Steeg PS
    J Natl Cancer Inst; 2012 Sep; 104(17):1306-19. PubMed ID: 22911670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
    David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
    Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.
    Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS
    Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
    J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
    Horak CE; Mendoza A; Vega-Valle E; Albaugh M; Graff-Cherry C; McDermott WG; Hua E; Merino MJ; Steinberg SM; Khanna C; Steeg PS
    Cancer Res; 2007 Dec; 67(24):11751-9. PubMed ID: 18089805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.
    David M; Sahay D; Mege F; Descotes F; Leblanc R; Ribeiro J; Clézardin P; Peyruchaud O
    PLoS One; 2014; 9(5):e97771. PubMed ID: 24828490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranilast inhibits the growth and metastasis of mammary carcinoma.
    Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
    Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.
    Zhang SH; Zhang H; He HW; Li L; Li XQ; Zhang YP; Shao RG
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):777-88. PubMed ID: 23975242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPA receptor1 antagonists as anticancer agents suppress human lung tumours.
    Zhao PF; Wu S; Li Y; Bao G; Pei JY; Wang YW; Ma Q; Sun HJ; Damirin A
    Eur J Pharmacol; 2020 Feb; 868():172886. PubMed ID: 31866407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
    Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
    Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.
    Khan I; Gril B; Steeg PS
    Cancer Res; 2019 Sep; 79(18):4689-4702. PubMed ID: 31311812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene.
    Marino N; Nakayama J; Collins JW; Steeg PS
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):593-603. PubMed ID: 22706779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.
    Rausch MP; Hahn T; Ramanathapuram L; Bradley-Dunlop D; Mahadevan D; Mercado-Pimentel ME; Runyan RB; Besselsen DG; Zhang X; Cheung HK; Lee WC; Ling LE; Akporiaye ET
    Anticancer Res; 2009 Jun; 29(6):2099-109. PubMed ID: 19528470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells.
    Okabe-Kado J; Hagiwara-Watanabe Y; Niitsu N; Kasukabe T; Kaneko Y
    Leuk Res; 2018 Mar; 66():39-48. PubMed ID: 29407582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma.
    Boissan M; Wendum D; Arnaud-Dabernat S; Munier A; Debray M; Lascu I; Daniel JY; Lacombe ML
    J Natl Cancer Inst; 2005 Jun; 97(11):836-45. PubMed ID: 15928304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
    Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
    Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.